NanoViricides
NNVC
#10366
Rank
ยฃ26.4 M
Marketcap
ยฃ1.15
Share price
0.66%
Change (1 day)
-11.30%
Change (1 year)

Earnings for NanoViricides (NNVC)

Earnings in 2026 (TTM): -ยฃ6.01 Million

According to NanoViricides's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ6.25 Million, an increase over its 2024 earnings that were of -ยฃ7.04 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for NanoViricides from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ6.01 Million-3.86%
2025 -ยฃ6.25 Million-11.17%
2024 -ยฃ7.04 Million0.09%
2023 -ยฃ7.03 Million35.83%
2022 -ยฃ5.18 Million-20.96%
2021 -ยฃ6.55 Million-40.3%
2020 -ยฃ10.97 Million86.2%
2019 -ยฃ5.89 Million0.09%
2018 -ยฃ5.89 Million-25.39%
2017 -ยฃ7.89 Million-6.68%
2016 -ยฃ8.45 Million114.25%
2015 -ยฃ3.95 Million-5.43%
2014 -ยฃ4.17 Million-59.73%
2013 -ยฃ10.36 Million106.16%
2012 -ยฃ5.03 Million5.57%
2011 -ยฃ4.76 Million6.42%
2010 -ยฃ4.48 Million93.61%
2009 -ยฃ2.31 Million-4.07%
2008 -ยฃ2.41 Million19.12%
2007 -ยฃ2.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
ยฃ8.05 B-132,691.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.87 B-162,651.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.20 B-118,713.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.51 B-123,835.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-ยฃ48.41 Million 696.69%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ0.35 Billion 5,513.34%๐Ÿ‡บ๐Ÿ‡ธ USA